Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Harlan, Ipsen in Early Stage Services Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Harlan, Ipsen in Early Stage Services Pact

Three-year program covers preclinical candidates

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Harlan Laboratories Contract Research Services (CRS) and Ipsen have strengthened their collaboration with a new business agreement. The companies have entered into a three-year program to develop early preclinical stage drug candidates, with exclusivity in some specific areas.

“This new agreement with Ipsen is in line with our strategy to satisfy the needs of the pharmaceutical industry in the preclinical arena and underlines our willingness to be close to our customers, helping them to make their drug candidates successful,” said Dr. Ciriaco Maraschiello, head of Global General Toxicology, Harlan Laboratories CRS. “We are delighted to be working with Ipsen and believe this collaboration will offer clients an unrivalled level of expertise and support in the early development of new drug formulations. This is a very important agreement which highlights our commitment to the Pharma sector and reinforces our presence in the drug discovery segment of the drug development process.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics